Cargando…

Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study

BACKGROUND: The neurofibromatoses (NF) are a group of genetic disorders that interfere negatively with the quality of life (QoL) and influence physical, emotional and social statuses. Studying the effects of neurofibromatoses on various aspects of QoL seems important to implement beneficial strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanagoo, Akram, Jouybari, Leila, Koohi, Fatemeh, Sayehmiri, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560778/
https://www.ncbi.nlm.nih.gov/pubmed/31189476
http://dx.doi.org/10.1186/s12883-019-1338-y
_version_ 1783426018805022720
author Sanagoo, Akram
Jouybari, Leila
Koohi, Fatemeh
Sayehmiri, Fatemeh
author_facet Sanagoo, Akram
Jouybari, Leila
Koohi, Fatemeh
Sayehmiri, Fatemeh
author_sort Sanagoo, Akram
collection PubMed
description BACKGROUND: The neurofibromatoses (NF) are a group of genetic disorders that interfere negatively with the quality of life (QoL) and influence physical, emotional and social statuses. Studying the effects of neurofibromatoses on various aspects of QoL seems important to implement beneficial strategies in increasing the QoL of NF patients. The aim of this study was to review the literature on quality of life in patients with NF and quantitatively evaluate the effects of Neurofibromatosis on various aspects of quality of life by synthesizing available studies. METHODS: This article is written according to the PRISMA checklist. Different databases including PubMed, Scopus, Google scholar and Web of Science were searched to identify studies that examined QoL of patients with neurofibromatosis. The relevant data obtained from these papers were analyzed by a random-effects model. The heterogeneity of studies was calculated using the I(2) index and Egger test was used to determine publication bias. The information was analyzed by R and STATA Ver 14. RESULTS: Twelve studies were selected as eligible for this research and were included in the final analysis. The number of participants in the study was 7314 individuals containing 910 NF patients (642 NF1 and 268 NF2) and 6404 healthy subjects. The mean scores of sub-scales of QoL were significantly lower in NF patients compared with control except for the scale of cohesion. Family and NF patients had lower quality of life in all aspects of QoL than controls. Also, this meta-analysis shows that NF negatively effects on physical function, bodily pain, mental health, social function and general health. Subgroup analysis showed that NF had negative effects on all sub-scales of QoL if the study was conducted in adults and used a SF-36 questionnaire. CONCLUSION: This meta-analysis suggests that NF is a broad spectrum disease, affecting physical function, bodily pain, mental health, social function and general health.
format Online
Article
Text
id pubmed-6560778
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65607782019-06-14 Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study Sanagoo, Akram Jouybari, Leila Koohi, Fatemeh Sayehmiri, Fatemeh BMC Neurol Research Article BACKGROUND: The neurofibromatoses (NF) are a group of genetic disorders that interfere negatively with the quality of life (QoL) and influence physical, emotional and social statuses. Studying the effects of neurofibromatoses on various aspects of QoL seems important to implement beneficial strategies in increasing the QoL of NF patients. The aim of this study was to review the literature on quality of life in patients with NF and quantitatively evaluate the effects of Neurofibromatosis on various aspects of quality of life by synthesizing available studies. METHODS: This article is written according to the PRISMA checklist. Different databases including PubMed, Scopus, Google scholar and Web of Science were searched to identify studies that examined QoL of patients with neurofibromatosis. The relevant data obtained from these papers were analyzed by a random-effects model. The heterogeneity of studies was calculated using the I(2) index and Egger test was used to determine publication bias. The information was analyzed by R and STATA Ver 14. RESULTS: Twelve studies were selected as eligible for this research and were included in the final analysis. The number of participants in the study was 7314 individuals containing 910 NF patients (642 NF1 and 268 NF2) and 6404 healthy subjects. The mean scores of sub-scales of QoL were significantly lower in NF patients compared with control except for the scale of cohesion. Family and NF patients had lower quality of life in all aspects of QoL than controls. Also, this meta-analysis shows that NF negatively effects on physical function, bodily pain, mental health, social function and general health. Subgroup analysis showed that NF had negative effects on all sub-scales of QoL if the study was conducted in adults and used a SF-36 questionnaire. CONCLUSION: This meta-analysis suggests that NF is a broad spectrum disease, affecting physical function, bodily pain, mental health, social function and general health. BioMed Central 2019-06-12 /pmc/articles/PMC6560778/ /pubmed/31189476 http://dx.doi.org/10.1186/s12883-019-1338-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sanagoo, Akram
Jouybari, Leila
Koohi, Fatemeh
Sayehmiri, Fatemeh
Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study
title Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study
title_full Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study
title_fullStr Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study
title_full_unstemmed Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study
title_short Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study
title_sort evaluation of qol in neurofibromatosis patients: a systematic review and meta-analysis study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560778/
https://www.ncbi.nlm.nih.gov/pubmed/31189476
http://dx.doi.org/10.1186/s12883-019-1338-y
work_keys_str_mv AT sanagooakram evaluationofqolinneurofibromatosispatientsasystematicreviewandmetaanalysisstudy
AT jouybarileila evaluationofqolinneurofibromatosispatientsasystematicreviewandmetaanalysisstudy
AT koohifatemeh evaluationofqolinneurofibromatosispatientsasystematicreviewandmetaanalysisstudy
AT sayehmirifatemeh evaluationofqolinneurofibromatosispatientsasystematicreviewandmetaanalysisstudy